BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15472611)

  • 1. Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts.
    Fleser PS; Nuthakki VK; Malinzak LE; Callahan RE; Seymour ML; Reynolds MM; Merz SI; Meyerhoff ME; Bendick PJ; Zelenock GB; Shanley CJ
    J Vasc Surg; 2004 Oct; 40(4):803-11. PubMed ID: 15472611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-producing polyurethanes.
    Jun HW; Taite LJ; West JL
    Biomacromolecules; 2005; 6(2):838-44. PubMed ID: 15762649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
    J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1α.
    De Visscher G; Mesure L; Meuris B; Ivanova A; Flameng W
    Acta Biomater; 2012 Mar; 8(3):1330-8. PubMed ID: 21964214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model.
    Walpoth BH; Zammaretti P; Cikirikcioglu M; Khabiri E; Djebaili MK; Pache JC; Tille JC; Aggoun Y; Morel D; Kalangos A; Hubbell JA; Zisch AH
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1163-70. PubMed ID: 17467424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic science review: nitric oxide--releasing prosthetic materials.
    Varu VN; Tsihlis ND; Kibbe MR
    Vasc Endovascular Surg; 2009; 43(2):121-31. PubMed ID: 18799500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
    Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
    J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
    Vijayan V; Shukla N; Johnson JL; Gadsdon P; Angelini GD; Smith FC; Baird R; Jeremy JY
    J Vasc Surg; 2004 Nov; 40(5):1011-9. PubMed ID: 15557918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia.
    Baek I; Bai CZ; Hwang J; Nam HY; Park JS; Kim DJ
    J Vasc Surg; 2012 Mar; 55(3):806-814.e1. PubMed ID: 22226184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrigel-coated stents reduce intimal thickening in a large animal vascular stent model.
    Tso C; Skinner MP; Hawthorne WJ; Fletcher JP
    Int Angiol; 2002 Sep; 21(3):244-9. PubMed ID: 12384645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.
    Kakkos SK; Andrzejewski T; Haddad JA; Haddad GK; Reddy DJ; Nypaver TJ; Scully MM; Schmid DL
    J Vasc Surg; 2008 Feb; 47(2):407-14. PubMed ID: 18155874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
    Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
    J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
    Torsney E; Mayr U; Zou Y; Thompson WD; Hu Y; Xu Q
    Circ Res; 2004 Jun; 94(11):1466-73. PubMed ID: 15117816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-eluting polyurethanes--vascular grafts of the future?
    Verma S; Marsden PA
    N Engl J Med; 2005 Aug; 353(7):730-1. PubMed ID: 16107627
    [No Abstract]   [Full Text] [Related]  

  • 15. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis.
    Lee BH; Nam HY; Kwon T; Kim SJ; Kwon GY; Jeon HJ; Lim HJ; Lee WK; Park JS; Ko JY; Kim DJ
    Nephrol Dial Transplant; 2006 Sep; 21(9):2432-8. PubMed ID: 16554328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healing characteristics of polymer-coated or collagen-treated Dacron grafts: an experimental porcine study.
    Pärsson H; Jundzill W; Johansson K; Jonung T; Norgren L
    Cardiovasc Surg; 1994 Apr; 2(2):242-8. PubMed ID: 8049955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-free fibrin coating on small caliber vascular prostheses has high antithrombogenicity in rabbit model.
    Hasegawa T; Okada K; Takano Y; Hiraishi Y; Okita Y
    Artif Organs; 2005 Nov; 29(11):880-6. PubMed ID: 16266301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid cellular luminal coverage of Dacron inferior vena cava prostheses in dogs by immediate seeding of autogenous endothelial cells derived from omental tissue: results of a preliminary trial.
    Wang ZG; Du W; Li GD; Pu LQ; Sharefkin JB
    J Vasc Surg; 1990 Aug; 12(2):168-79. PubMed ID: 2143236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
    Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study.
    Conte MS; Nugent HM; Gaccione P; Guleria I; Roy-Chaudhury P; Lawson JH
    J Vasc Surg; 2009 Dec; 50(6):1359-68.e1. PubMed ID: 19958986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.